Literature DB >> 16952220

Antioxidative and in vitro hepatoprotective activity of Bupleurum kaoi leaf infusion.

Chu-Ting Liu1, Pei-Ting Chuang, Ching-Yi Wu, Yih-Ming Weng, Wenlung Chen, Chin-Yin Tseng.   

Abstract

The roots of Bupleurus spp. have been used in traditional Chinese herbal medicine for curing liver diseases. Although bioactive saikosaponins have been detected in the leaves as well as in the roots, the aerial parts of the plants are discarded as waste. In the present study, a leaf infusion of B. kaoi Liu, Chao et Chuang, an indigenous Bupleurus species in Taiwan, was prepared and the antioxidant properties and in vitro hepatoprotective activity were demonstrated. The results show that the leaf infusion exerted DPPH free radical scavenging activity, inhibitory capacity on superoxide anion formation and superoxide anion scavenging activity. The hepatotoxicity of acetaminophen (APAP) and carbon tetrachloride (CCl4) on the rat liver cells were also decreased by the leaf infusion. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952220     DOI: 10.1002/ptr.1946

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

1.  Caffeic acid derivatives from Bupleurum chinense.

Authors:  G Haghi; A Hatami; M Mehran; H Hosseini
Journal:  Res Pharm Sci       Date:  2014 Sep-Oct

2.  Flavonoid profiles of three Bupleurum species and in vitro hepatoprotective of activity Bupleurum flavum Forsk.

Authors:  Reneta Gevrenova; Magdalena Kondeva-Burdina; Nikolay Denkov; Dimitrina Zheleva-Dimitrova
Journal:  Pharmacogn Mag       Date:  2015 Jan-Mar       Impact factor: 1.085

Review 3.  Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview.

Authors:  Divya Singh; William C Cho; Ghanshyam Upadhyay
Journal:  Front Physiol       Date:  2016-01-26       Impact factor: 4.566

Review 4.  Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action.

Authors:  Mohamed L Ashour; Michael Wink
Journal:  J Pharm Pharmacol       Date:  2010-11-16       Impact factor: 3.765

5.  A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study.

Authors:  Manish V Patel; Kalapi B Patel; Shivenarain Gupta; Andreas Michalsen; Elmar Stapelfeldt; Christian S Kessler
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-03       Impact factor: 2.629

Review 6.  Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.

Authors:  Ming Hong; Sha Li; Hor Yue Tan; Ning Wang; Sai-Wah Tsao; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923

Review 7.  Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview.

Authors:  Alex Boye; Yan Yang; James Asenso; Wei Wei
Journal:  J Intercult Ethnopharmacol       Date:  2016-06-14

Review 8.  Traditional Use, Pharmacology, Toxicology, and Quality Control of Species in Genus Bupleurum L.

Authors:  Ru-Yu Yao; Yuan-Feng Zou; Xing-Fu Chen
Journal:  Chin Herb Med       Date:  2013-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.